Showing results 1 to 5 of 5
Biological characterization of angiopoietin-3 and angiopoietin-4 Lee, HJ; Cho, CH; Hwang, SJ; Choi, HH; Kim, KT; Ahn, SY; Kim, JH; et al, FASEB JOURNAL, v.18, pp.1200 - 1208, 2004-08 |
EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin-1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells Kim, Injune; Ryu, YS; Kwak, HJ; Ahn, SY; Oh, JL; Yancopoulos, GD; Gale, NW; et al, FASEB JOURNAL, v.16, no.7, pp.1126 - 1126, 2002-05 |
Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2 Kim, KT; Choi, HH; Steinmetz, MO; Maco, B; Kammerer, RA; Ahn, SY; Kim, HZ; et al, JOURNAL OF BIOLOGICAL CHEMISTRY, v.280, pp.20126 - 20131, 2005-05 |
Protective effect of alpha-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression Sung, MJ; Kim, W; Ahn, SY; Cho, CH; Koh, Gou Young; Moon, SO; Kim, DH; et al, CIRCULATION RESEARCH, v.97, no.9, pp.880 - 890, 2005-10 |
Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression Ahn, SY; Cho, CH; Park, KY; Lee, HJ; Lee, S; Park, SK; Lee, IK; et al, AMERICAN JOURNAL OF PATHOLOGY, v.164, no.5, pp.1663 - 1672, 2004-05 |
Discover